[Metabolic effects of xylitol during long-term parenteral administration in internal diseases].
D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000378:metabolism; D001806:Blood Urea Nitrogen; D002675:Child, Preschool; D003677:Deficiency Diseases / Q000188:drug therapy; D005632:Fructose / Q000627:therapeutic use*; D005947:Glucose / Q000627:therapeutic use*; D006801:Humans; D007019:Hypoproteinemia; D007362:Intensive Care Units; D010710:Phosphates / Q000097:blood; D013997:Time Factors; D014527:Uric Acid / Q000097:blood; D014993:Xylitol / Q000627:therapeutic use*
D001798:Blood Proteins; D010710:Phosphates; D014527:Uric Acid; D005632:Fructose; D005947:Glucose; D001663:Bilirubin; D014993:Xylitol
Metabolische Wirkungen von Xylit während langdauernder parenteraler Zufuhrbei internistischen Erkrankungen.